William Blair Downgrades CVS Caremark (CVS) to Market Perform
More News related to CVS
- MinuteClinic Opens First Retail Clinic in Washington, D.C. at CVS/pharmacy Store in Northeast
- Brower Piven Encourages Investors Who Have Losses in Excess of $300,000 From Investment in CVS Caremark Corporation to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsui
- CVS/pharmacy Kicks Off Annual Thanks and Giving(R) Campaign for the St. Jude Children's Research Hospital
- Stull, Stull & Brody Announces Class Action on Behalf of Shareholders of CVS Caremark Corporation
- Shalov Stone Bonner & Rocco LLP Announces Class Action Against CVS Caremark Corporation
More News related to Downgrades
- Superior Bancorp (SUPR) To Double Mortgage Banking Operation
- Carpenter Technology (CRS) Completes $200 Million Syndicated Credit Facility
- Integrated Electrical Services Awarded Contract from U.S. Army Medical Research Institute of Infectious Diseases
- New York State Renews Lottery Contract with International Gaming (IGT) Through 2017
- TiVo (TIVO) and Virgin Media (VMED) Enter Strategic Partnership for NextGen TV Platform
William Blair downgrades CVS Caremark (NYSE: CVS) from Outperform to Market Perform.
To see more analyst ratings on CVS Click Here.
CVS Caremark Corporation, a pharmacy services company, provides prescriptions and related healthcare services in the United States.
Related Categories
DowngradesStocks Mentioned
-0.28Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
